NHLBI’s Clinical Asthma Research Network (AsthmaNet)’s Approach to Key Asthma Questions in Children and Adults
Saturday, March 4, 2017: 10:45 AM-12:00 PM
Georgia World Congress Center, Building B, Level 3, Rooms B308-B309
1.25 CME/CE
Primary Moderators:
William Busse , MD FAAAAI
James Kiley , PhD

Learning Objectives:
  1. Discuss whether alendronate, which diminishes beta-2 adrenergic receptor internalization in vitro and ex vivo, can reduce the loss of bronchoprotection that occurs with regular use of long-acting beta agonists (LABAs)
  2. Discuss the results of a study to evaluate the association of treatment response in young children with early Step 2 asthma with urine metabolomics patterns
  3. Discuss the role of vitamin D in colds and asthma
10:45 AM
The Role of Alendronate in Asthma
Juan C. Cardet, MD
11:05 AM
Question & Answer
11:10 AM
Metabolomics Analysis to Predict Treatment Response in Early Asthma
Stanley J. Szefler, MD FAAAAI
11:30 AM
Question & Answer
11:35 AM
Vitamin D Supplementation and Risk of Colds in Patients with Asthma
Loren C. Denlinger, MD PhD
11:55 AM
Question & Answer
See more of: Session